Point-of-Care CD4 Monitoring in HIV Healthcare

Point-of-care CD4 monitoring has emerged as a transformative approach to HIV management by enabling rapid assessment of immune status at or near the site of patient care. CD4+ T lymphocytes are the primary targets of HIV, and their enumeration is essential for staging disease, guiding antiretroviral therapy (ART) initiation where viral load monitoring is unavailable, and identifying individuals with advanced disease. Conventional laboratory-based CD4 testing often involves centralised facilities, prolonged turnaround times and logistical challenges that can delay clinical decision making and impede linkage to care, particularly in resource-limited settings. Point-of-care platforms, such as portable immunoassay and image-based cell counters, have been developed to provide near-patient CD4 counts within minutes, facilitating same-visit results and immediate clinical action. These devices combine simplified sample preparation, robust quality controls and user-friendly interfaces to function in decentralised clinics, mobile units and community settings. The global decline in routine laboratory CD4 measurements underscores the need for decentralised alternatives, as late presentation with advanced immunosuppression persists in many regions. By reducing the time between testing and clinical intervention, point-of-care CD4 monitoring supports timely ART initiation, improves patient retention in the care cascade and strengthens the operational capacity of HIV programmes. Ongoing innovation focuses on enhancing analytical accuracy, reducing device error rates, minimising maintenance requirements and integrating data connectivity for remote monitoring. As the HIV care paradigm shifts towards universal treatment and differentiated service delivery, point-of-care CD4 monitoring remains a vital component of comprehensive strategies to manage advanced disease and ensure equitable access to diagnostic services worldwide.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Point-of-Care CD4 Monitoring in HIV Healthcare publication trend

The graph below shows the total number of articles in point-of-care cd4 monitoring in hiv healthcare across all publications each year (not limited to Nature Index journals).

Technical terms

CD4+ T lymphocytes: White blood cells that express the CD4 receptor, central to adaptive immunity and targeted by HIV.

Point-of-care testing: Diagnostic procedures performed at the site of patient care, delivering rapid results without reliance on central laboratories.

Flow cytometry: A laboratory technique that uses light scattering and fluorescence to count and characterise cells in a fluid suspension.

Antiretroviral therapy (ART): Combination drug regimens that suppress HIV replication to preserve immune function and reduce morbidity.

References

1. Point of Care CD4 Testing in National Household Surveys – Results and Quality Indicators from Eleven Population-Based HIV Impact Assessment (PHIA) Surveys. Microbiology Spectrum (2023).
2. Performance Evaluation of Microscanner Plus, an Automated Image-Based Cell Counter, for Counting CD4+ T Lymphocytes in HIV Patients. Diagnostics (2023).
3. Global Trends in CD4 Count Measurement and Distribution at First Antiretroviral Treatment Initiation. Clinical Infectious Diseases (2024).